Pan-resistant HIV-1 emergence in the era of integrase strand-transfer inhibitors: a case report

Summary: Background: In 2019, WHO reported that the prevalence of HIV-1 drug resistance to first-line regimens of non-nucleoside reverse transcriptase inhibitors is increasing in countries with a low number of therapeutic options. This increasing prevalence of drug resistance is an important threat...

Full description

Bibliographic Details
Main Authors: Maria C Puertas, PhD, George Ploumidis, MD, Michalis Ploumidis, MD, Emilio Fumero, MD, Bonaventura Clotet, MD, Charles M Walworth, MD, Christos J Petropoulos, PhD, Javier Martinez-Picado, PhD
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:The Lancet Microbe
Online Access:http://www.sciencedirect.com/science/article/pii/S2666524720300069